Search For "bharat biotech international"
Bharat Biotech to advance development of GSK's Shigella vaccine candidate
Updated : 12 months ago IST
Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and manufacturing on Thursday announced that it has partnered with GSK plc (LSE/NYSE: GSK) for the ongoing development and potential use of the Shigella vaccine candidate, altSonflex1-2-3.
Read More
Bharat Biotech launches oral vaccine against cholera, targets 200 million
Updated : 1 year, 9 months ago IST
Bharat Biotech International has launched a novel single-strain Oral Cholera Vaccine (OCV).
Read More
Expert committee approves Bharat Biotech International's proposal to condu
Updated : 2 years, 1 month ago IST
The Subject Expert Committee (SEC) under the Central Drug Standard Control Organisation (CDSCO) has approved vaccine major Bharat Biotech International's proposal to conduct the Phase II clinical trial of Mycobacterium Tuberculosis (Live Attenuated) Vaccine to assess the safety and immunogen
Read More
Bharat Biotech, institute Sydney ID partner to combat infectious diseases
Updated : 2 years, 6 months ago IST
Bharat Biotech is a world-leading vaccine and biotherapeutics manufacturer. During the Covid pandemic, it made the vaccine Covaxin, which was administered by millions across the globe
Read More
iNCOVACC is a testimony to innovative zeal of our scientists: Mansukh Mand
Updated : 3 years, 4 months ago IST
Mandaviya unveiled the Inncovacc- the first India-made nasal Covid-19 vaccine today in the presence of Union Minister of State (IC) for Science and Technology, Jitendra Singh.
Read More
India-made iNCOVACC, world's first intra-nasal vaccine to receive approval
Updated : 3 years, 6 months ago IST
iNCOVACC, on Tuesday, became the world's first intra-nasal vaccine to receive both Primary series and Heterologous booster approval, Bharat Biotech International Limited (BBIL) announced
Read More
Nigeria introduces Bharat Biotech's Rotavac vaccine to immunise children
Updated : 3 years, 9 months ago IST
Hyderabad (Telangana) [India], August 24 (ANI): Bharat Biotech International Limited (BBIL), the Indian vaccines and bio-therapeutics manufacturer, on Wednesday announced that its rotavirus oral vaccine ROTAVAC has been introduced to immunise its children from the life-threatening diarrhoeal
Read More
Bharat Biotech completes clinical development for phase III trials, booste
Updated : 3 years, 9 months ago IST
Hyderabad (Telangana) [India], August 15 (ANI): Bharat Biotech International on Monday said that BBV154 (intranasal vaccine) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.
Read More
Covaxin safe for children aged 2-18 years, says Bharat Biotech
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], June 17 (ANI): Bharat Biotech International Limited (BBIL) on Thursday announced that Covaxin, its whole-virion inactivated COVID-19 vaccine has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study, said a press
Read More
Indian Immunologicals hands over first lot of Covaxin drug substance to Bh
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], August 13 (ANI): In order to augment the Covid-19 vaccine production capacity in our country so that a significant percentage of the population can get vaccinated at the earliest, the Central Government requested that Indian Immunologicals Limited (IIL) and Bha
Read More
COVAXIN shows 81 pc efficiency in phase three trials, says ICMR
Updated : 5 years, 3 months ago IST
New Delhi [India], March 3 (ANI): Phase three results of the COVAXIN, a vaccine against COVID-19 which has been developed by Indian Council of Medical Research (ICMR) in partnership with Bharat Biotech International Limited (BBIL), has shown an interim vaccine efficacy of 81 per cent in p
Read More
'A powerful example for all Indians': Bharat Biotech after PM Modi receive
Updated : 5 years, 3 months ago IST
Hyderabad (Telangana) [India], March 1 (ANI): Bharat Biotech International Limited (BBIL), the Indian vaccines and bio-therapeutics manufacturer that developed the country's indigenous COVID-19 vaccine, Covaxin, on Monday welcomed Prime Minister Narendra Modi's gesture of taking the first do
Read More